Saturday - September 25, 2021
MD Anderson Cancer: Glioblastoma Study Discovers Protective Role of Metabolic Enzyme, Revealing a Novel Therapeutic Target
May 27, 2021
HOUSTON, Texas, May 27 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on May 26, 2021:

Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel function for the metabolic enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in glioblastoma (GBM). MCAD prevents toxic lipid buildup, in addition to its normal role in energy production, so targeting MCAD causes irreversible damage and cell death specifically . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products